| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |